Jan Louise Henry
About Jan Louise Henry
Jan Louise Henry, Esq.
Senior Partner | Crestfield at Law, P.C.
Jan Louise Henry, Esq. is a Senior Partner at Crestfield at Law, P.C., where her practice focuses on U.S. corporate and securities law. She advises businesses, investors, and entrepreneurs on a broad range of complex transactions, including venture capital financing, private equity investments, mergers and acquisitions (M&A), securities offerings, and capital markets transactions. She has extensive experience representing clients in the financial services industry and providing strategic legal counsel on corporate governance, financing, and regulatory compliance.
Ms. Henry earned her Juris Doctor (J.D.) from Thomas Jefferson School of Law. During law school, she served as Editor-in-Chief of the Corporate Governance and Accountability Review, demonstrating exceptional leadership and a strong commitment to legal scholarship.
Admitted to the State Bar of California on December 10, 1993, Ms. Henry has practiced with major law firms in California, representing clients in a wide range of corporate and commercial matters. In recognition of her legal expertise, she has also served as a guest lecturer at several universities in the United States, where she has taught courses on American jurisprudence and the U.S. legal system.
Drawing on decades of experience in California's business law sector, Ms. Henry is committed to advancing innovative legal service models and delivering practical, results-oriented counsel. She is dedicated to providing sophisticated legal solutions tailored to the evolving needs of entrepreneurs, investors, and growing businesses in an increasingly global marketplace.
Today, Ms. Henry continues to represent clients in matters involving corporate governance, capital markets, mergers and acquisitions, venture financing, private equity, and financial regulatory compliance, offering trusted legal counsel to businesses at every stage of growth.
Education
Professional Affiliations
Bar Admissions
Languages
Representative Experience
- Advise Chijet Motor Company, Inc. (Nasdaq: CJET), as sellers, in its business combination with Jupiter Wellness Acquisition Corp. (Nasdaq: JWAC), whereby the sellers received a share exchange in the surviving corporation that had an aggregate value equal to $1,600,000,000;
- Advise Great Wall Seafood Supply, Inc., Great Wall Restaurant Supplier, Inc., First Mart, Inc. and Sealand Food Inc. (“collectively, the Great Wall Group”), as the seller, in its simultaneous signing and closing in its sale to HR Foods Group Inc. (Nasdaq: HFFG) for $70,000,000;
- Advise Zoomcar, Inc., an India-based car rental platform, as the seller, with its signing of a business combination agreement with the acquirer, Innovative International Acquisition Corp. (Nasdaq: IOAC);
- Advise the MICT, Inc. (Nasdaq: MICT), on its 100% acquisition of Tingo, Inc. (OTC: TMNA), a leading Agri-Fintech company operating in Africa;
- Advise the Hainan Manaslu Acquisition Corp. (Nasdaq: HMAC), with its signing of a business combination agreement with Able View Inc., a leading brand manager in China;
- Advise Emergency Medical Services LP Corporation in its sale of Evolution Health LLC to Amedisys, Inc. (Nasdaq: AMED) for $70,000,000;
- Advise Radiology Partners in its partial sale of its membership interests in Middle Tennessee Imaging, LLC to Saint Thomas Health for $28,000,000;
- Advise Radiology Partners in its purchase of Western Colorado Radiologic Associates, Inc. and Wellington Imaging Partners, LLC for a base consideration of $44,370,000;
- Advise Digital World Acquisition Corp., a publicly listed entity (Nasdaq: DWAC), in its signing of a business combination agreement with Trump Media & Technology Group;
- Advise China state owned renewable energy company in its 100% acquisition of two private wind plants in Spain;
- Advise Chinese fund in its 85% acquisition of a private semiconductor company in Malaysia, with subsidiaries in Malaysia, China, and the United States;
- Advise a top-tier fund in its 100% acquisition of a multinational British semiconductor company;
- Advise semiconductor company in its auction bid to acquire 100% of a semiconductor fab manufacturer in Japan (client not selected to proceed); and,
- Advise Chinese fund in its auction bid to acquire 100% of a semiconductor company in Malaysia (client was not selected to proceed).
- Advise a Texas-based powersports vehicle manufacturer, as the issuer, on its planned initial public offering and preparation of its Form S-1 registration statement;
- Advise CytoMed Therapeutics Pte. Ltd. (Nasdaq: GDTC), a biotechnology Singapore-based issuer, on its planned initial public offering and preparation of its Form F-1 registration statement;
- Advise The Benchmark Company, LLC, as the underwriter, in a China-based logistics company’s planned Form F-1 initial public offering;
- Advise the Hainan Manaslu Acquisition Corp., as the acquirer of Able View, Inc. a leading brand manager in China, with its filing of the Form F-4;
- Advise underwriters in connection with various SPAC related offerings; and,
- Routinely prepare corporate securities filings for publicly listed companies pursuant to the 34 Act, including but not limited to Form 8-K. disclosures.
- Advise a tier 1 Asia-based private equity fund on its USD $10,000,000 convertible note investment in the pre-IPO round of financing for a China-based shared workspace company; and,
- Advise top tier United States-based private equity fund in connection to an alleged related party. transaction concerning its Series D round investment into a biotech company.
